| | | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2023 ( Subtotal = $4,013,621 ) |
| 2023 | 2023 | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., THE | 6720-A ROCKLEDGE DR STE 100 | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01HL167048 | COVID-19 airway inflammation is due to Spike inhibition of CFTR signaling | 000 | 1 | NIH | 1/11/2023 | $573,412 |
| 2023 | 2023 | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., THE | 6720-A ROCKLEDGE DR STE 100 | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01AI141961 | Role of the enterococcal site 2 protease in biofilm formation, adaptation, and host-pathogen interactions | 000 | 5 | NIH | 12/21/2022 | $369,989 |
| 2023 | 2023 | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., THE | 6720-A ROCKLEDGE DR STE 100 | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01GM117155 | Regulation of microtubule organizing centers during mammalian gametogenesis | 000 | 9 | NIH | 12/22/2022 | $307,986 |
| 2023 | 2023 | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., THE | 6720-A ROCKLEDGE DR STE 100 | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | UM1AI108568 | The Military HIV Research Program (MHRP) Clinical Trial Unit | 001 | 10 | NIH | 11/25/2022 | $178,164 |
| 2023 | 2023 | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., THE | 6720-A ROCKLEDGE DR STE 100 | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | UM1AI108568 | The Military HIV Research Program (MHRP) Clinical Trial Unit | 001 | 10 | NIH | 11/25/2022 | $829,348 |
| 2023 | 2023 | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., THE | 6720-A ROCKLEDGE DR STE 100 | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21AI173635 | HTLV-1 Replication/Reactivation-Induced DNA Damage: Mechanisms and Pathogenesis | 000 | 1 | NIH | 11/14/2022 | $227,793 |
| 2023 | 2023 | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., THE | 6720-A ROCKLEDGE DR STE 100 | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01AI147627 | Plasmodium falciparum gametocytogenesis in vitro and in vivo | 000 | 4 | NIH | 12/14/2022 | $506,597 |
| 2023 | 2023 | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., THE | 6720-A ROCKLEDGE DR STE 100 | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01HL167048 | COVID-19 airway inflammation is due to Spike inhibition of CFTR signaling | 001 | 1 | NIH | 1/23/2023 | $90,189 |
| 2023 | 2023 | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., THE | 6720-A ROCKLEDGE DR STE 100 | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R00HD099520 | Molecular analysis of MEHMO syndrome mutations in translation factor eIF2 | 000 | 3 | NIH | 12/15/2022 | $222,323 |
| 2023 | 2023 | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., THE | 6720-A ROCKLEDGE DR STE 100 | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01NS119594 | Calcium Dysregulation and Cell Function in Spinal Muscular Atrophy | 001 | 3 | NIH | 1/26/2023 | $28,559 |
| 2023 | 2023 | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., THE | 6720-A ROCKLEDGE DR STE 100 | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01NS119594 | Calcium Dysregulation and Cell Function in Spinal Muscular Atrophy | 000 | 3 | NIH | 1/12/2023 | $343,117 |
| 2023 | 2023 | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., THE | 6720-A ROCKLEDGE DR STE 100 | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R35GM139619 | Temporal and Metabolic Regulation of Restimulation-Induced Cell Death (RICD) in Human T Cells | 000 | 3 | NIH | 12/8/2022 | $343,117 |
| 2023 | 2022 | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., THE | 6720-a Rockledge Dr Ste 100 | Bethesda | MD | 20817-1891 | MONTGOMERY | USA | R01CE003270 | Firearm Behavioral Practices and Suicide Risk in U.S. Army Soldiers and Veterans | 07 | 2 | CDC | 10/25/2022 | $0 |
| 2023 | 2022 | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., THE | 6720-A ROCKLEDGE DR STE 100 | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | U19AI144180 | The Gonorrhea Vaccine Cooperative Research Center | 000 | 4 | NIH | 11/2/2022 | $0 |
| 2023 | 2022 | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., THE | 6720-A ROCKLEDGE DR STE 100 | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | U19AI142764 | Advancement of Vaccines and Therapies for Henipaviruses | 000 | 4 | NIH | 12/8/2022 | $0 |
| 2023 | 2022 | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., THE | 6720-A ROCKLEDGE DR STE 100 | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01GM117155 | Regulation of microtubule organizing centers during mammalian gametogenesis | 002 | 8 | NIH | 12/29/2022 | $21,465 |
| 2023 | 2022 | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., THE | 6720-A ROCKLEDGE DR STE 100 | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21NS126890 | FL2 siRNA as a Novel Therapeutic Option to Induce Spinal Cord Regeneration Following Injury | 000 | 1 | NIH | 12/9/2022 | $0 |
| 2023 | 2022 | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., THE | 6720-A ROCKLEDGE DR STE 100 | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | F31AA029932 | Impact of the COVID-19 Pandemic on Alcohol Use and Outcomes: The Role of Health Disparities | 000 | 1 | NIH | 1/23/2023 | $0 |
| 2023 | 2022 | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., THE | 6720-a Rockledge Dr Ste 100 | Bethesda | MD | 20817-1891 | MONTGOMERY | USA | U01OH012485 | Grief and health-related quality of life in WTCHR Survivors: Associations with bereavement, trauma exposures, and mental and physical health conditions | 01 | 1 | CDC | 12/1/2022 | $0 |
| 2023 | 2022 | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., THE | 6720-A ROCKLEDGE DR STE 100 | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21AR081008 | Does joint lavage reduce intraarticular inflammation in high-energy tibial pilon fractures? | 000 | 1 | NIH | 12/20/2022 | $0 |
| 2023 | 2020 | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., THE | 6720-A ROCKLEDGE DR STE 100 | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21NS116710 | Characterization of neuronal derived exosomes to detect biomarkers for neurodegenerative disorders | 000 | 1 | NIH | 10/26/2022 | $0 |
| 2023 | 2020 | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., THE | 6720-A ROCKLEDGE DR STE 100 | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | F31MH119762 | Neural Underpinnings of Anxiety in Relation to Eating Behaviors in Adolescence | 000 | 2 | NIH | 11/23/2022 | -$4,794 |
| 2023 | 2019 | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., THE | 6720-A ROCKLEDGE DR STE 100 | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21AI140038 | A Novel Helicobacter pylori Strain to Study Gastric Cancer Development | 000 | 2 | NIH | 12/8/2022 | $0 |
| 2023 | 2019 | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., THE | 6720-A ROCKLEDGE DR STE 100 | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01HL130448 | Design of Less Immunogenic Factor VIII Proteins | 000 | 4 | NIH | 12/2/2022 | $0 |
| 2023 | 2018 | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., THE | 6720-A ROCKLEDGE DR STE 100 | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | U19AI113170 | The Atlantic Coast Sexually Transmitted Infection Cooperative Research Center (AC | 000 | 5 | NIH | 12/20/2022 | -$1,546 |
| 2023 | 2018 | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., THE | 6720-A ROCKLEDGE DR STE 100 | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | U19AI113170 | The Atlantic Coast Sexually Transmitted Infection Cooperative Research Center (AC | 000 | 5 | NIH | 12/20/2022 | -$22,097 |
| 2023 | 2017 | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., THE | 6720-A ROCKLEDGE DR STE 100 | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01AI020148 | Pathogenicity of Shiga Toxin Producing E.coli | 000 | 35 | NIH | 10/1/2022 | -$1 |
|
 | Issue Date FY: 2022 ( Subtotal = $22,261,583 ) (Continued on the next page) |
| 2022 | 2022 | Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc., The | 6720-a Rockledge Dr Ste 100 | Bethesda | MD | 20817-1891 | MONTGOMERY | USA | U01OH012485 | Grief and health-related quality of life in WTCHR Survivors: Associations with bereavement, trauma exposures, and mental and physical health conditions | 00 | 1 | CDC | 8/5/2022 | $499,996 |
| 2022 | 2022 | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., THE | 6720-A ROCKLEDGE DR STE 100 | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | UM1AI108568 | The Military HIV Research Program (MHRP) Clinical Trial Unit | 004 | 9 | NIH | 6/27/2022 | $161,924 |
| 2022 | 2022 | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., THE | 6720-A ROCKLEDGE DR STE 100 | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | UM1AI108568 | The Military HIV Research Program (MHRP) Clinical Trial Unit | 004 | 9 | NIH | 6/27/2022 | $685,953 |
| 2022 | 2022 | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., THE | 6720-A ROCKLEDGE DR STE 100 | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | UM1AI108568 | The Military HIV Research Program (MHRP) Clinical Trial Unit | 003 | 9 | NIH | 2/15/2022 | $42,798 |
| 2022 | 2022 | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., THE | 6720-A ROCKLEDGE DR STE 100 | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | UM1AI108568 | The Military HIV Research Program (MHRP) Clinical Trial Unit | 002 | 9 | NIH | 11/30/2021 | $253,266 |
| 2022 | 2022 | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., THE | 6720-A ROCKLEDGE DR STE 100 | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | UM1AI108568 | The Military HIV Research Program (MHRP) Clinical Trial Unit | 002 | 9 | NIH | 11/30/2021 | $1,072,901 |
| 2022 | 2022 | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., THE | 6720-A ROCKLEDGE DR STE 100 | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21AI166122 | Not all members of the pregnancy-specific glycoprotein family are created equal | 000 | 1 | NIH | 4/29/2022 | $189,916 |
| 2022 | 2022 | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., THE | 6720-A ROCKLEDGE DR STE 100 | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | U01AI170033 | Mitigation of Radiation Induced Immune Dysfunction by PrC-210 Treatment | 000 | 1 | NIH | 8/17/2022 | $488,484 |
| 2022 | 2022 | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., THE | 6720-A ROCKLEDGE DR STE 100 | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21NS126890 | FL2 siRNA as a Novel Therapeutic Option to Induce Spinal Cord Regeneration Following Injury | 000 | 1 | NIH | 9/23/2022 | $425,702 |
| 2022 | 2022 | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., THE | 6720-A ROCKLEDGE DR STE 100 | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01AA030041 | Leveraging genetic and electronic health record data to identify novel targets and drugs for treating alcohol use disorder | 000 | 1 | NIH | 5/26/2022 | $553,341 |
| 2022 | 2022 | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., THE | 6720-A ROCKLEDGE DR STE 100 | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R00NS112612 | The Mechanisms and Functional Consequences of Interhemispheric Plasticity | 000 | 2 | NIH | 5/12/2022 | $249,000 |
| 2022 | 2022 | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., THE | 6720-A ROCKLEDGE DR STE 100 | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | F31AA029932 | Impact of the COVID-19 Pandemic on Alcohol Use and Outcomes: The Role of Health Disparities | 000 | 1 | NIH | 6/1/2022 | $29,652 |
| 2022 | 2022 | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., THE | 6720-A ROCKLEDGE DR STE 100 | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | F31AA029932 | Impact of the COVID-19 Pandemic on Alcohol Use and Outcomes: The Role of Health Disparities | 001 | 1 | NIH | 6/1/2022 | $0 |
| 2022 | 2022 | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., THE | 6720-A ROCKLEDGE DR STE 100 | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21AI171791 | Host Ca2+, actin, and ATP production in rickettsia-endothelial cell dysfunction | 000 | 1 | NIH | 7/5/2022 | $227,793 |
| 2022 | 2022 | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., THE | 6720-A ROCKLEDGE DR STE 100 | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21AR081008 | Does joint lavage reduce intraarticular inflammation in high-energy tibial pilon fractures? | 000 | 1 | NIH | 8/5/2022 | $89,757 |
| 2022 | 2022 | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., THE | 6720-A ROCKLEDGE DR STE 100 | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21AI172041 | NK cell memory subsets and their impact on HIV disease progression and vaccination | 000 | 1 | NIH | 7/28/2022 | $219,278 |
| 2022 | 2022 | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., THE | 6720-A ROCKLEDGE DR STE 100 | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | F31MH129104 | Examining Suicide Risk from a Biopsychosocial Framework: A Large-Scale Cross-Sectional Study | 001 | 1 | NIH | 7/26/2022 | $0 |
| 2022 | 2022 | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., THE | 6720-A ROCKLEDGE DR STE 100 | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | F31MH129104 | Examining Suicide Risk from a Biopsychosocial Framework: A Large-Scale Cross-Sectional Study | 000 | 1 | NIH | 7/26/2022 | $30,752 |
| 2022 | 2022 | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., THE | 6720-A ROCKLEDGE DR STE 100 | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21AA029782 | Thalamostriatal circuit contributions to behavioral inflexibility following adolescent ethanol exposure | 000 | 1 | NIH | 2/25/2022 | $181,089 |
| 2022 | 2022 | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., THE | 6720-A ROCKLEDGE DR STE 100 | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R00HD099520 | Molecular analysis of MEHMO syndrome mutations in translation factor eIF2 | 000 | 2 | NIH | 1/24/2022 | $248,999 |
| 2022 | 2022 | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., THE | 6720-A ROCKLEDGE DR STE 100 | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21CA256424 | Use of Ly6K specific CAR T-cells to treat primary and metastatic triple negative breast cancer | 000 | 2 | NIH | 8/31/2022 | $174,666 |
|